These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An approach to the evaluation and treatment of Cushing's disease. Brown RL; Weiss RE Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S37-46. PubMed ID: 17004856 [TBL] [Abstract][Full Text] [Related]
7. Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease. Grant P; Dworakowska D; Carroll P Clin Endocrinol (Oxf); 2012 Apr; 76(4):555-9. PubMed ID: 22017348 [TBL] [Abstract][Full Text] [Related]
8. Subclinical Cushing's syndrome: definition and management. Terzolo M; Pia A; Reimondo G Clin Endocrinol (Oxf); 2012 Jan; 76(1):12-8. PubMed ID: 21988204 [TBL] [Abstract][Full Text] [Related]
9. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease. Romanholi DJ; Machado MC; Pereira CC; Danilovic DS; Pereira MA; Cescato VA; Cunha Neto MB; Musolino NR; de Mendonça BB; Salgado LR Clin Endocrinol (Oxf); 2008 Jul; 69(1):117-22. PubMed ID: 18182093 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. Peters CJ; Ahmed ML; Storr HL; Davies KM; Martin LJ; Allgrove J; Grossman AB; Savage MO Horm Res; 2007; 68(5):231-5. PubMed ID: 17389813 [TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with Cushing's disease: a modern approach. Colao A; Cozzolino A; Pivonello R Clin Endocrinol (Oxf); 2012 Jun; 76(6):776-7. PubMed ID: 22260180 [No Abstract] [Full Text] [Related]
12. Hypopituitarism in Cushing's disease. Cavagnini F; Scacchi M; Pecori Giraldi F J Endocrinol Invest; 2008 Sep; 31(9 Suppl):44-7. PubMed ID: 19020385 [TBL] [Abstract][Full Text] [Related]
13. Markers of vascular function in hypertension due to Cushing's syndrome. Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437 [TBL] [Abstract][Full Text] [Related]
14. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
15. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661 [TBL] [Abstract][Full Text] [Related]
16. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease. Esfahanian F; Kazemi R Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933 [TBL] [Abstract][Full Text] [Related]
17. Cushing's disease: diagnosis through the nose. A case report. Unuane D; D'Haens J; Van Rompaey K; Halewyck S; Poppe K; Velkeniers B Acta Clin Belg; 2012; 67(5):381-3. PubMed ID: 23189551 [TBL] [Abstract][Full Text] [Related]
18. Angio-oedema after trans-sphenoidal surgery in a patient with Cushing's disease. Okan G; Muhammedrezai S; Vural P Allergol Immunopathol (Madr); 2011; 39(1):52-3. PubMed ID: 20655139 [No Abstract] [Full Text] [Related]
19. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome. Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740 [TBL] [Abstract][Full Text] [Related]
20. Preserved GLP-1 effects in a diabetic patient with Cushing's disease. Ritzel RA; Kleine N; Holst JJ; Willms B; Schmiegel W; Nauck MA Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):146-50. PubMed ID: 17318778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]